-
1
-
-
0037153029
-
Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus
-
Hulscher JB, van Sandick JW, de Boer AG, Wijnhoven BP, Tijssen JG, Fockens P, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med. 2002;347:1662-9.
-
(2002)
N Engl J Med.
, vol.347
, pp. 1662-1669
-
-
Hulscher, J.B.1
Van Sandick, J.W.2
De Boer, A.G.3
Wijnhoven, B.P.4
Tijssen, J.G.5
Fockens, P.6
-
2
-
-
36549086516
-
Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: Five-year survival of a randomized clinical trial
-
Omloo JM, Lagarde SM, Hulscher JB, Reitsma JB, Fockens P, van Dekken H, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial. Ann Surg. 2007;246:992-1001.
-
(2007)
Ann Surg.
, vol.246
, pp. 992-1001
-
-
Omloo, J.M.1
Lagarde, S.M.2
Hulscher, J.B.3
Reitsma, J.B.4
Fockens, P.5
Van Dekken, H.6
-
3
-
-
33745726677
-
Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer
-
Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355:11-20.
-
(2006)
N Engl J Med.
, vol.355
, pp. 11-20
-
-
Cunningham, D.1
Allum, W.H.2
Stenning, S.P.3
Thompson, J.N.4
Van De Velde, C.J.5
Nicolson, M.6
-
4
-
-
33847156303
-
Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: A meta-analysis
-
Gebski V, Burmeister B, Smithers BM, Foo K, Zalcberg J, Simes J. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol. 2007;8:226-34.
-
(2007)
Lancet Oncol.
, vol.8
, pp. 226-234
-
-
Gebski, V.1
Burmeister, B.2
Smithers, B.M.3
Foo, K.4
Zalcberg, J.5
Simes, J.6
-
5
-
-
34548516386
-
Long-term results of RTOG trial 8911 (USA Intergroup 113): A random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer
-
Kelsen DP, Winter KA, Gunderson LL, Mortimer J, Estes NC, Haller DG, et al. Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer. J Clin Oncol. 2007;25:3719-25.
-
(2007)
J Clin Oncol.
, vol.25
, pp. 3719-3725
-
-
Kelsen, D.P.1
Winter, K.A.2
Gunderson, L.L.3
Mortimer, J.4
Estes, N.C.5
Haller, D.G.6
-
6
-
-
33646825826
-
Neoadjuvant concurrent chemoradiation with weekly paclitaxel and carboplatin for patients with oesophageal cancer: A phase II study
-
van Meerten E., Muller K, Tilanus HW, Siersema PD, Eijkenboom WM, van Dekken H, et al. Neoadjuvant concurrent chemoradiation with weekly paclitaxel and carboplatin for patients with oesophageal cancer: a phase II study. Br J Cancer. 2006;94:1389-94.
-
(2006)
Br J Cancer
, vol.94
, pp. 1389-1394
-
-
Van Meerten, E.1
Muller, K.2
Tilanus, H.W.3
Siersema, P.D.4
Eijkenboom, W.M.5
Van Dekken, H.6
-
7
-
-
0035371059
-
Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: Final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone
-
Ancona E, Ruol A, Santi S, Merigliano S, Sileni VC, Koussis H, et al. Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone. Cancer. 2001;91:2165-74.
-
(2001)
Cancer
, vol.91
, pp. 2165-2174
-
-
Ancona, E.1
Ruol, A.2
Santi, S.3
Merigliano, S.4
Sileni, V.C.5
Koussis, H.6
-
8
-
-
0036176751
-
Positron emission tomography scanning: Current and future applications
-
Czernin J, Phelps ME. Positron emission tomography scanning: current and future applications. Annu Rev Med. 2002;53:89-112.
-
(2002)
Annu Rev Med.
, vol.53
, pp. 89-112
-
-
Czernin, J.1
Phelps, M.E.2
-
9
-
-
0035021707
-
A tabulated summary of the FDG PET literature
-
Gambhir SS, Czernin J, Schwimmer J, Silverman DH, Coleman RE, Phelps ME. A tabulated summary of the FDG PET literature. J Nucl Med. 2001;42:1S-93S.
-
(2001)
J Nucl Med.
, vol.42
-
-
Gambhir, S.S.1
Czernin, J.2
Schwimmer, J.3
Silverman, D.H.4
Coleman, R.E.5
Phelps, M.E.6
-
11
-
-
0034666024
-
Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma
-
Flamen P, Lerut A, Van CE, Cambier JP, Maes A, De Wever W, et al. Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. J Clin Oncol. 2000;18:3202-10.
-
(2000)
J Clin Oncol.
, vol.18
, pp. 3202-3210
-
-
Flamen, P.1
Lerut, A.2
Van, C.E.3
Cambier, J.P.4
Maes, A.5
De Wever, W.6
-
12
-
-
10844270611
-
The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma
-
Kato H, Miyazaki T, Nakajima M, Takita J, Kimura H, Faried A, et al. The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma. Cancer. 2005;103:148-56.
-
(2005)
Cancer
, vol.103
, pp. 148-156
-
-
Kato, H.1
Miyazaki, T.2
Nakajima, M.3
Takita, J.4
Kimura, H.5
Faried, A.6
-
13
-
-
37249028331
-
Limited additional value of positron emission tomography in staging oesophageal cancer
-
van Westreenen HL, Westerterp M, Sloof GW, Groen H, Bossuyt PM, Jager PL, et al. Limited additional value of positron emission tomography in staging oesophageal cancer. Br J Surg. 2007;94; 1515-20.
-
(2007)
Br J Surg.
, vol.94
, pp. 1515-1520
-
-
Van Westreenen, H.L.1
Westerterp, M.2
Sloof, G.W.3
Groen, H.4
Bossuyt, P.M.5
Jager, P.L.6
-
14
-
-
34548185461
-
PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: The MUNICON phase II trial
-
Lordick F, Ott K, Krause BJ, Weber WA, Becker K, Stein HJ, et al. PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial. Lancet Oncol. 2007;8:797-805.
-
(2007)
Lancet Oncol.
, vol.8
, pp. 797-805
-
-
Lordick, F.1
Ott, K.2
Krause, B.J.3
Weber, W.A.4
Becker, K.5
Stein, H.J.6
-
15
-
-
23844455598
-
Esophageal cancer: CT, endoscopic US, and FDG PET for assessment of response to neoadjuvant therapy-systematic review
-
Westerterp M, van Westreenen HL, Reitsma JB, Hoekstra OS, Stoker J, Fockens P, et al. Esophageal cancer: CT, endoscopic US, and FDG PET for assessment of response to neoadjuvant therapy-systematic review. Radiology. 2005;236:841-51.
-
(2005)
Radiology
, vol.236
, pp. 841-851
-
-
Westerterp, M.1
Van Westreenen, H.L.2
Reitsma, J.B.3
Hoekstra, O.S.4
Stoker, J.5
Fockens, P.6
-
16
-
-
33646394620
-
Monitoring of response to pre-operative chemoradiation in combination with hyperthermia in oesophageal cancer by FDG-PET
-
Westerterp M, Omloo JM, Sloof GW, Hulshof MC, Hoekstra OS, Crezee H, et al. Monitoring of response to pre-operative chemoradiation in combination with hyperthermia in oesophageal cancer by FDG-PET. Int J Hyperthermia. 2006;22:149-60.
-
(2006)
Int J Hyperthermia.
, vol.22
, pp. 149-160
-
-
Westerterp, M.1
Omloo, J.M.2
Sloof, G.W.3
Hulshof, M.C.4
Hoekstra, O.S.5
Crezee, H.6
-
17
-
-
41949084786
-
Prognostic stratification of stage IIIA-N2 nonsmall-cell lung cancer after induction chemotherapy: A model based on the combination of morphometric-pathologic response in mediastinal nodes and primary tumor response on serial 18-fluoro-2-deoxy-glucose positron emission tomography
-
Dooms C, Verbeken E, Stroobants S, Nackaerts K, De Leyn P, Vansteenkiste J. Prognostic stratification of stage IIIA-N2 nonsmall-cell lung cancer after induction chemotherapy: a model based on the combination of morphometric- pathologic response in mediastinal nodes and primary tumor response on serial 18-fluoro-2-deoxy-glucose positron emission tomography. J Clin Oncol. 2008;26:1128-34.
-
(2008)
J Clin Oncol.
, vol.26
, pp. 1128-1134
-
-
Dooms, C.1
Verbeken, E.2
Stroobants, S.3
Nackaerts, K.4
De Leyn, P.5
Vansteenkiste, J.6
-
18
-
-
0036789344
-
Methods to monitor response to chemotherapy in non-small cell lung cancer with 18F-FDG PET
-
Hoekstra CJ, Hoekstra OS, Stroobants SG, Vansteenkiste J, Nuyts J, Smit EF, et al. Methods to monitor response to chemotherapy in non-small cell lung cancer with 18F-FDG PET. J Nucl Med. 2002;43:1304-9.
-
(2002)
J Nucl Med.
, vol.43
, pp. 1304-1309
-
-
Hoekstra, C.J.1
Hoekstra, O.S.2
Stroobants, S.G.3
Vansteenkiste, J.4
Nuyts, J.5
Smit, E.F.6
-
19
-
-
33644663786
-
Prognostic relevance of response evaluation using [18F]-2-fluoro-2-deoxy- D-glucose positron emission tomography in patients with locally advanced nonsmall-cell lung cancer
-
Hoekstra CJ, Stroobants SG, Smit EF, Vansteenkiste J, van Tinteren H, Postmus PE, et al. Prognostic relevance of response evaluation using [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with locally advanced nonsmall-cell lung cancer. J Clin Oncol. 2005;23:8362-70.
-
(2005)
J Clin Oncol.
, vol.23
, pp. 8362-8370
-
-
Hoekstra, C.J.1
Stroobants, S.G.2
Smit, E.F.3
Vansteenkiste, J.4
Van Tinteren, H.5
Postmus, P.E.6
-
20
-
-
17644421807
-
Effects of ROI definition and reconstruction method on quantitative outcome and applicability in a response monitoring trial
-
Krak NC, Boellaard R, Hoekstra OS, Twisk JW, Hoekstra CJ, Lammertsma AA. Effects of ROI definition and reconstruction method on quantitative outcome and applicability in a response monitoring trial. Eur J Nucl Med Mol Imaging. 2005;32:294-301.
-
(2005)
Eur J Nucl Med Mol Imaging
, vol.32
, pp. 294-301
-
-
Krak, N.C.1
Boellaard, R.2
Hoekstra, O.S.3
Twisk, J.W.4
Hoekstra, C.J.5
Lammertsma, A.A.6
-
21
-
-
33947512956
-
Use of positron emission tomography for response assessment of lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma
-
Juweid ME, Stroobants S, Hoekstra OS, Mottaghy FM, Dietlein M, Guermazi A, et al. Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. J Clin Oncol. 2007;25:571-8.
-
(2007)
J Clin Oncol.
, vol.25
, pp. 571-578
-
-
Juweid, M.E.1
Stroobants, S.2
Hoekstra, O.S.3
Mottaghy, F.M.4
Dietlein, M.5
Guermazi, A.6
-
22
-
-
3242716152
-
Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-[18F]fluoro-2-deoxy-D-glucose
-
Allal AS, Slosman DO, Kebdani T, Allaoua M, Lehmann W, Dulguerov P. Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-[18F]fluoro-2-deoxy-D-glucose. Int J Radiat Oncol Biol Phys. 2004;59:1295-300.
-
(2004)
Int J Radiat Oncol Biol Phys.
, vol.59
, pp. 1295-1300
-
-
Allal, A.S.1
Slosman, D.O.2
Kebdani, T.3
Allaoua, M.4
Lehmann, W.5
Dulguerov, P.6
-
23
-
-
4344714364
-
Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection
-
Downey RJ, Akhurst T, Gonen M, Vincent A, Bains MS, Larson S, et al. Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection. J Clin Oncol. 2004;22:3255-60.
-
(2004)
J Clin Oncol.
, vol.22
, pp. 3255-3260
-
-
Downey, R.J.1
Akhurst, T.2
Gonen, M.3
Vincent, A.4
Bains, M.S.5
Larson, S.6
-
24
-
-
0036203470
-
Prognostic value of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography imaging for patients with prostate cancer
-
Oyama N, Akino H, Suzuki Y, Kanamaru H, Miwa Y, Tsuka H, et al. Prognostic value of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography imaging for patients with prostate cancer. Mol Imaging Biol. 2002;4:99-104.
-
(2002)
Mol Imaging Biol.
, vol.4
, pp. 99-104
-
-
Oyama, N.1
Akino, H.2
Suzuki, Y.3
Kanamaru, H.4
Miwa, Y.5
Tsuka, H.6
-
25
-
-
19944432837
-
Prognostic significance of preoperative [18-F] fluorodeoxyglucose (FDG) positron emission tomography (PET) imaging in patients with resectable soft tissue sarcomas
-
Schwarzbach MH, Hinz U, Dmitrakopoulou-Strauss A, Willeke F, Cardona S, Mechtersheimer G, et al. Prognostic significance of preoperative [18-F] fluorodeoxyglucose (FDG) positron emission tomography (PET) imaging in patients with resectable soft tissue sarcomas. Ann Surg. 2005;241:286-94.
-
(2005)
Ann Surg.
, vol.241
, pp. 286-294
-
-
Schwarzbach, M.H.1
Hinz, U.2
Dmitrakopoulou-Strauss, A.3
Willeke, F.4
Cardona, S.5
Mechtersheimer, G.6
-
26
-
-
0028893611
-
In vitro comparison of cell proliferation kinetics and uptake of tritiated fluorodeoxyglucose and L-methionine in squamous-cell carcinoma of the head and neck
-
Minn H, Clavo AC, Grenman R, Wahl RL. In vitro comparison of cell proliferation kinetics and uptake of tritiated fluorodeoxyglucose and L-methionine in squamous-cell carcinoma of the head and neck. J Nucl Med. 1995;36:252-8.
-
(1995)
J Nucl Med.
, vol.36
, pp. 252-258
-
-
Minn, H.1
Clavo, A.C.2
Grenman, R.3
Wahl, R.L.4
-
27
-
-
6944235697
-
Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: A simulation study
-
Boellaard R, Krak NC, Hoekstra OS, Lammertsma AA. Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study. J Nucl Med. 2004;45:1519-27.
-
(2004)
J Nucl Med.
, vol.45
, pp. 1519-1527
-
-
Boellaard, R.1
Krak, N.C.2
Hoekstra, O.S.3
Lammertsma, A.A.4
-
28
-
-
6944256515
-
Understanding the standardized uptake value, its methods, and implications for usage
-
Thie JA. Understanding the standardized uptake value, its methods, and implications for usage. J Nucl Med. 2004;45:1431-4.
-
(2004)
J Nucl Med.
, vol.45
, pp. 1431-1434
-
-
Thie, J.A.1
-
29
-
-
0033983927
-
How to perform a comprehensive search for FDG-PET literature
-
Mijnhout GS, Hooft L, van Tulder MW, Devillé WL, Teule GJ, Hoekstra OS. How to perform a comprehensive search for FDG-PET literature. Eur J Nucl Med. 2000;27:91-7.
-
(2000)
Eur J Nucl Med.
, vol.27
, pp. 91-97
-
-
Mijnhout, G.S.1
Hooft, L.2
Van Tulder, M.W.3
Devillé, W.L.4
Teule, G.J.5
Hoekstra, O.S.6
-
30
-
-
33746102928
-
Maximum standardized uptake values on positron emission tomography of esophageal cancer predicts stage, tumor biology, and survival
-
Cerfolio RJ, Bryant AS. Maximum standardized uptake values on positron emission tomography of esophageal cancer predicts stage, tumor biology, and survival. Ann Thorac Surg. 2006;82:391-4.
-
(2006)
Ann Thorac Surg.
, vol.82
, pp. 391-394
-
-
Cerfolio, R.J.1
Bryant, A.S.2
-
31
-
-
16544394930
-
18F-FDG PET in patients with esophageal squamous cell carcinoma undergoing curative surgery: Prognostic implications
-
Choi JY, Jang HJ, Shim YM, Kim K, Lee KS, Lee KH, et al. 18F-FDG PET in patients with esophageal squamous cell carcinoma undergoing curative surgery: prognostic implications. J Nucl Med. 2004;45:1843-50.
-
(2004)
J Nucl Med.
, vol.45
, pp. 1843-1850
-
-
Choi, J.Y.1
Jang, H.J.2
Shim, Y.M.3
Kim, K.4
Lee, K.S.5
Lee, K.H.6
-
32
-
-
33748357297
-
Prognostic significance of vascular endothelial growth factor expression and microvessel density in esophageal squamous cell carcinoma: Comparison with positron emission tomography
-
Choi JY, Jang KT, Shim YM, Kim K, Ahn G, Lee KH, et al. Prognostic significance of vascular endothelial growth factor expression and microvessel density in esophageal squamous cell carcinoma: comparison with positron emission tomography. Ann Surg Oncol. 2006;13:1054-62.
-
(2006)
Ann Surg Oncol.
, vol.13
, pp. 1054-1062
-
-
Choi, J.Y.1
Jang, K.T.2
Shim, Y.M.3
Kim, K.4
Ahn, G.5
Lee, K.H.6
-
33
-
-
0031811481
-
Evaluation of esophageal cancers using fluorine-18-fluorodeoxyglucose PET
-
Fukunaga T, Okazumi S, Koide Y, Isono K, Imazeki K. Evaluation of esophageal cancers using fluorine-18-fluorodeoxyglucose PET. J Nucl Med. 1998;39:1002-7.
-
(1998)
J Nucl Med.
, vol.39
, pp. 1002-1007
-
-
Fukunaga, T.1
Okazumi, S.2
Koide, Y.3
Isono, K.4
Imazeki, K.5
-
34
-
-
26444557983
-
Value of baseline positron emission tomography for predicting overall survival in patient with nonmetastatic esophageal or gastroesophageal junction carcinoma
-
Hong D, Lunagomez S, Kim EE, Lee JH, Bresalier RS, Swisher SG, et al. Value of baseline positron emission tomography for predicting overall survival in patient with nonmetastatic esophageal or gastroesophageal junction carcinoma. Cancer. 2005;104:1620-6.
-
(2005)
Cancer
, vol.104
, pp. 1620-1626
-
-
Hong, D.1
Lunagomez, S.2
Kim, E.E.3
Lee, J.H.4
Bresalier, R.S.5
Swisher, S.G.6
-
35
-
-
0037083439
-
Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma
-
Kato H, Kuwano H, Nakajima M, Miyazaki T, Yoshikawa M, Ojima H, et al. Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma. Cancer. 2002;94:921-8.
-
(2002)
Cancer
, vol.94
, pp. 921-928
-
-
Kato, H.1
Kuwano, H.2
Nakajima, M.3
Miyazaki, T.4
Yoshikawa, M.5
Ojima, H.6
-
36
-
-
0042029374
-
Correlation of 18-F-fluorodeoxyglucose (FDG) accumulation with glucose transporter (Glut-1) expression in esophageal squamous cell carcinoma
-
Kato H, Takita J, Miyazaki T, Nakajima M, Fukai Y, Masuda N, et al. Correlation of 18-F-fluorodeoxyglucose (FDG) accumulation with glucose transporter (Glut-1) expression in esophageal squamous cell carcinoma. Anticancer Res. 2003;23:3263-72.
-
(2003)
Anticancer Res.
, vol.23
, pp. 3263-3272
-
-
Kato, H.1
Takita, J.2
Miyazaki, T.3
Nakajima, M.4
Fukai, Y.5
Masuda, N.6
-
37
-
-
34548492286
-
Correlation of molecular response as measured by 18-FDG positron emission tomography with outcome after chemoradiotherapy in patients with esophageal carcinoma
-
Konski AA, Cheng JD, Goldberg M, Li T, Maurer A, Yu JQ, et al. Correlation of molecular response as measured by 18-FDG positron emission tomography with outcome after chemoradiotherapy in patients with esophageal carcinoma. Int J Radiat Oncol Biol Phys. 2007;69:358-63.
-
(2007)
Int J Radiat Oncol Biol Phys.
, vol.69
, pp. 358-363
-
-
Konski, A.A.1
Cheng, J.D.2
Goldberg, M.3
Li, T.4
Maurer, A.5
Yu, J.Q.6
-
38
-
-
34548463451
-
FDG-PET/CT tumor segmentation-derived indices of metabolic activity to assess response to neoadjuvant therapy and progression-free survival in esophageal cancer: Correlation with histopathology Results
-
Mamede M, Abreu-e-Lima, Oliva MR, Nosé V, Mamon H, Gerbaudo VH. FDG-PET/CT tumor segmentation-derived indices of metabolic activity to assess response to neoadjuvant therapy and progression-free survival in esophageal cancer: correlation with histopathology Results. Am J Clin Oncol. 2007;30:377-88.
-
(2007)
Am J Clin Oncol.
, vol.30
, pp. 377-388
-
-
Mamede, M.1
Abreu-E-Lima2
Oliva, M.R.3
Nosé, V.4
Mamon, H.5
Gerbaudo, V.H.6
-
39
-
-
32644457820
-
Preoperative 18[F]-fluorodeoxyglucose positron emission tomography standardized uptake values predict survival after esophageal adenocarcinoma resection
-
Rizk N, Downey RJ, Akhurst T, Gonen M, Bains MS, Larson S, et al. Preoperative 18[F]-fluorodeoxyglucose positron emission tomography standardized uptake values predict survival after esophageal adenocarcinoma resection. Ann Thorac Surg. 2006;81:1076-81.
-
(2006)
Ann Thorac Surg.
, vol.81
, pp. 1076-1081
-
-
Rizk, N.1
Downey, R.J.2
Akhurst, T.3
Gonen, M.4
Bains, M.S.5
Larson, S.6
-
40
-
-
29744451139
-
FDG PET and CT in locally advanced adenocarcinomas of the distal oesophagus. Clinical relevance of a discordant PET finding
-
Stahl A, Stollfuss J, Ott K, Wieder H, Fink U, Schwaiger M, et al. FDG PET and CT in locally advanced adenocarcinomas of the distal oesophagus. Clinical relevance of a discordant PET finding. Nuklearmedizin. 2005;44:249-55.
-
(2005)
Nuklearmedizin
, vol.44
, pp. 249-255
-
-
Stahl, A.1
Stollfuss, J.2
Ott, K.3
Wieder, H.4
Fink, U.5
Schwaiger, M.6
-
41
-
-
4744354764
-
2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma
-
Swisher SG, Erasmus J, Maish M, Correa AM, Macapinlac H, Ajani JA, et al. 2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma. Cancer. 2004;101:1776-85.
-
(2004)
Cancer
, vol.101
, pp. 1776-1785
-
-
Swisher, S.G.1
Erasmus, J.2
Maish, M.3
Correa, A.M.4
Macapinlac, H.5
Ajani, J.A.6
-
42
-
-
4644225878
-
Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer
-
Swisher SG, Maish M, Erasmus JJ, Correa AM, Ajani JA, Bresalier R, et al. Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer. Ann Thorac Surg. 2004;78:1152-60.
-
(2004)
Ann Thorac Surg.
, vol.78
, pp. 1152-1160
-
-
Swisher, S.G.1
Maish, M.2
Erasmus, J.J.3
Correa, A.M.4
Ajani, J.A.5
Bresalier, R.6
-
43
-
-
25644443260
-
Prognostic value of the standardized uptake value in esophageal cancer
-
van Westreenen HL, Plukker JT, Cobben DC, Verhoogt CJ, Groen H, Jager PL. Prognostic value of the standardized uptake value in esophageal cancer. Am J Roentgenol. 2005;185:436-40.
-
(2005)
Am J Roentgenol.
, vol.185
, pp. 436-440
-
-
Van Westreenen, H.L.1
Plukker, J.T.2
Cobben, D.C.3
Verhoogt, C.J.4
Groen, H.5
Jager, P.L.6
-
44
-
-
36849039415
-
(18) FDG uptake in oesophageal adenocarcinoma: Linking biology and outcome
-
Westerterp M, Sloof GW, Hoekstra OS, Ten Kate FJ, Meijer GA, Reitsma JB, et al. (18) FDG uptake in oesophageal adenocarcinoma: linking biology and outcome. J Cancer Res Clin Oncol. 2008;134:227-36.
-
(2008)
J Cancer Res Clin Oncol.
, vol.134
, pp. 227-236
-
-
Westerterp, M.1
Sloof, G.W.2
Hoekstra, O.S.3
Ten Kate, F.J.4
Meijer, G.A.5
Reitsma, J.B.6
-
45
-
-
0037317691
-
Whole body 18FDG-PET and the response of esophageal cancer to induction therapy: Results of a prospective trial
-
Downey RJ, Akhurst T, Ilson D, Ginsberg R, Bains MS, Gonen M, et al. Whole body 18FDG-PET and the response of esophageal cancer to induction therapy: results of a prospective trial. J Clin Oncol. 2003;21:428-32.
-
(2003)
J Clin Oncol.
, vol.21
, pp. 428-432
-
-
Downey, R.J.1
Akhurst, T.2
Ilson, D.3
Ginsberg, R.4
Bains, M.S.5
Gonen, M.6
-
46
-
-
33645468927
-
Predictive value of 18-fluoro-deoxy-glucose-positron emission tomography (18F-FDG-PET) in the identification of responders to chemoradiation therapy for the treatment of locally advanced esophageal cancer
-
Levine EA, Farmer MR, Clark P, Mishra G, Ho C, Geisinger KR, et al. Predictive value of 18-fluoro-deoxy-glucose-positron emission tomography (18F-FDG-PET) in the identification of responders to chemoradiation therapy for the treatment of locally advanced esophageal cancer. Ann Surg. 2006;243:472-8.
-
(2006)
Ann Surg.
, vol.243
, pp. 472-478
-
-
Levine, E.A.1
Farmer, M.R.2
Clark, P.3
Mishra, G.4
Ho, C.5
Geisinger, K.R.6
-
47
-
-
33750578261
-
Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction
-
Ott K, Weber WA, Lordick F, Becker K, Busch R, Herrmann K, et al. Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction. J Clin Oncol. 2006;24:4692-8.
-
(2006)
J Clin Oncol.
, vol.24
, pp. 4692-4698
-
-
Ott, K.1
Weber, W.A.2
Lordick, F.3
Becker, K.4
Busch, R.5
Herrmann, K.6
-
48
-
-
34447559791
-
Positron emission tomographic scanning predicts survival after induction chemotherapy for esophageal carcinoma
-
Port JL, Lee PC, Korst RJ, Liss Y, Meherally D, Christos P, et al. Positron emission tomographic scanning predicts survival after induction chemotherapy for esophageal carcinoma. Ann Thorac Surg. 2007;84:393-400.
-
(2007)
Ann Thorac Surg.
, vol.84
, pp. 393-400
-
-
Port, J.L.1
Lee, P.C.2
Korst, R.J.3
Liss, Y.4
Meherally, D.5
Christos, P.6
-
49
-
-
0035876401
-
Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging
-
Weber WA, Ott K, Becker K, Dittler HJ, Helmberger H, Avril NE, et al. Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging. J Clin Oncol. 2001;19:3058-65.
-
(2001)
J Clin Oncol.
, vol.19
, pp. 3058-3065
-
-
Weber, W.A.1
Ott, K.2
Becker, K.3
Dittler, H.J.4
Helmberger, H.5
Avril, N.E.6
-
50
-
-
1542503721
-
Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment
-
Wieder HA, Brucher BL, Zimmermann F, Becker K, Lordick F, Beer A, et al. Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment. J Clin Oncol. 2004;22:900-8.
-
(2004)
J Clin Oncol.
, vol.22
, pp. 900-908
-
-
Wieder, H.A.1
Brucher, B.L.2
Zimmermann, F.3
Becker, K.4
Lordick, F.5
Beer, A.6
-
51
-
-
36749006570
-
Prediction of tumor response by FDG-PET: Comparison of the accuracy of single and sequential studies in patients with adenocarcinomas of the esophagogastric junction
-
Wieder HA, Ott K, Lordick F, Becker K, Stahl A, Herrmann K, et al. Prediction of tumor response by FDG-PET: comparison of the accuracy of single and sequential studies in patients with adenocarcinomas of the esophagogastric junction. Eur J Nucl Med Mol Imaging. 2007;34:1925-32.
-
(2007)
Eur J Nucl Med Mol Imaging
, vol.34
, pp. 1925-1932
-
-
Wieder, H.A.1
Ott, K.2
Lordick, F.3
Becker, K.4
Stahl, A.5
Herrmann, K.6
-
52
-
-
60549111970
-
Positron emission tomography changes management and prognostic stratification in patients with oesophageal cancer: Results of a multicentre prospective study
-
Chatterton BE, Ho S, I, Baldey A, Baldey A, Lenzo N, Patrikeos A, et al. Positron emission tomography changes management and prognostic stratification in patients with oesophageal cancer: results of a multicentre prospective study. Eur J Nucl Med Mol Imaging. 2009;36:354-61.
-
(2009)
Eur J Nucl Med Mol Imaging
, vol.36
, pp. 354-361
-
-
Chatterton, B.E.1
Ho, S.I.2
Baldey, A.3
Baldey, A.4
Lenzo, N.5
Patrikeos, A.6
-
53
-
-
49649089535
-
Prognostic value of initial fluorodeoxyglucose-PET in esophageal cancer: A prospective study
-
Cheze-Le Rest C., Metges JP, Teyton P, Jestin-Le Tallec V, Lozac'h P, Volant A, et al. Prognostic value of initial fluorodeoxyglucose-PET in esophageal cancer: a prospective study. Nucl Med Commun. 2008;29:628-35.
-
(2008)
Nucl Med Commun.
, vol.29
, pp. 628-635
-
-
Rest, C.C.-L.1
Metges, J.P.2
Teyton, P.3
Tallec, V.J.-L.4
Lozac'h, P.5
Volant, A.6
-
54
-
-
46049107516
-
Lack of fludeoxyglucose F 18 uptake in posttreatment positron emission tomography as a significant predictor of survival after subsequent surgery in multimodality treatment for patients with locally advanced esophageal squamous cell carcinoma
-
Higuchi I, Yasuda T, Yano M, Doki Y, Miyata H, Tatsumi M, et al. Lack of fludeoxyglucose F 18 uptake in posttreatment positron emission tomography as a significant predictor of survival after subsequent surgery in multimodality treatment for patients with locally advanced esophageal squamous cell carcinoma. J Thorac Cardiovasc Surg. 2008;136:205-12.
-
(2008)
J Thorac Cardiovasc Surg.
, vol.136
, pp. 205-212
-
-
Higuchi, I.1
Yasuda, T.2
Yano, M.3
Doki, Y.4
Miyata, H.5
Tatsumi, M.6
-
55
-
-
53949111150
-
Use of (18) F-fluorodeoxyglucose-positron emission tomography to evaluate responses to neo-adjuvant chemotherapy for primary tumor and lymph node metastasis in esophageal squamous cell carcinoma
-
Makino T, Doki Y, Miyata H, Yasuda T, Yamasaki M, Fujiwara Y, et al. Use of (18) F-fluorodeoxyglucose-positron emission tomography to evaluate responses to neo-adjuvant chemotherapy for primary tumor and lymph node metastasis in esophageal squamous cell carcinoma. Surgery. 2008;144:793-802.
-
(2008)
Surgery
, vol.144
, pp. 793-802
-
-
Makino, T.1
Doki, Y.2
Miyata, H.3
Yasuda, T.4
Yamasaki, M.5
Fujiwara, Y.6
-
56
-
-
46249119582
-
Importance of fluorodeoxyglucose-positron emission tomography (FDG-PET) and endoscopic ultrasonography parameters in predicting survival following surgery for esophageal cancer
-
Omloo JM, Sloof GW, Boellaard R, Hoekstra OS, Jager PL, van Dullemen HM, et al. Importance of fluorodeoxyglucose-positron emission tomography (FDG-PET) and endoscopic ultrasonography parameters in predicting survival following surgery for esophageal cancer. Endoscopy. 2008;40:464-71.
-
(2008)
Endoscopy
, vol.40
, pp. 464-471
-
-
Omloo, J.M.1
Sloof, G.W.2
Boellaard, R.3
Hoekstra, O.S.4
Jager, P.L.5
Van Dullemen, H.M.6
-
57
-
-
56949099284
-
Adenocarcinomas of the esophagus: Response to chemoradiotherapy is associated with decrease of metabolic tumor volume as measured on PET-CT. Comparison to histopathologic and clinical response evaluation
-
Roedl JB, Colen RR, Holalkere NS, Fischman AJ, Choi NC, Blake MA. Adenocarcinomas of the esophagus: response to chemoradiotherapy is associated with decrease of metabolic tumor volume as measured on PET-CT. Comparison to histopathologic and clinical response evaluation. Radiother Oncol. 2008;89:278-86.
-
(2008)
Radiother Oncol.
, vol.89
, pp. 278-286
-
-
Roedl, J.B.1
Colen, R.R.2
Holalkere, N.S.3
Fischman, A.J.4
Choi, N.C.5
Blake, M.A.6
-
58
-
-
59449097399
-
Metabolic tumor width parameters as determined on PET/CT predict disease-free survival and treatment response in squamous cell carcinoma of the esophagus
-
Roedl JB, Halpern EF, Colen RR, Sahani DV, Fischman AJ, Blake MA. Metabolic tumor width parameters as determined on PET/CT predict disease-free survival and treatment response in squamous cell carcinoma of the esophagus. Mol Imaging Biol. 2009;11:54-60.
-
(2009)
Mol Imaging Biol.
, vol.11
, pp. 54-60
-
-
Roedl, J.B.1
Halpern, E.F.2
Colen, R.R.3
Sahani, D.V.4
Fischman, A.J.5
Blake, M.A.6
-
59
-
-
64649094846
-
Mean and maximum standardized uptake values in [18F]FDG-PET for assessment of histopathological response in oesophageal squamous cell carcinoma or adenocarcinoma after radiochemotherapy
-
Schmidt M, Bollschweiler E, Dietlein M, Mönig SP, Kobe C, Vallböhmer D, et al. Mean and maximum standardized uptake values in [18F]FDG-PET for assessment of histopathological response in oesophageal squamous cell carcinoma or adenocarcinoma after radiochemotherapy. Eur J Nucl Med Mol Imaging. 2009;36:735-44.
-
(2009)
Eur J Nucl Med Mol Imaging
, vol.36
, pp. 735-744
-
-
Schmidt, M.1
Bollschweiler, E.2
Dietlein, M.3
Mönig, S.P.4
Kobe, C.5
Vallböhmer, D.6
-
60
-
-
74649087061
-
Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma
-
Hyun SH, Choi JY, Shim YM, Kim K, Lee SJ, Cho YS, et al. Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma. Ann Surg Oncol. 2010;17:115-22.
-
(2010)
Ann Surg Oncol.
, vol.17
, pp. 115-122
-
-
Hyun, S.H.1
Choi, J.Y.2
Shim, Y.M.3
Kim, K.4
Lee, S.J.5
Cho, Y.S.6
-
61
-
-
33847159680
-
Quantification of FDG PET studies using standardised uptake values in multi-centre trials: Effects of image reconstruction, resolution and ROI definition parameters
-
Westerterp M, Pruim J, Oyen W, Hoekstra O, Paans A, Visser E, et al. Quantification of FDG PET studies using standardised uptake values in multi-centre trials: effects of image reconstruction, resolution and ROI definition parameters. Eur J Nucl Med Mol Imaging. 2007;34:392-404.
-
(2007)
Eur J Nucl Med Mol Imaging
, vol.34
, pp. 392-404
-
-
Westerterp, M.1
Pruim, J.2
Oyen, W.3
Hoekstra, O.4
Paans, A.5
Visser, E.6
-
62
-
-
33746485010
-
How should we analyse FDG PET studies for monitoring tumour response?
-
Lammertsma AA, Hoekstra CJ, Giaccone G, Hoekstra OS. How should we analyse FDG PET studies for monitoring tumour response? Eur J Nucl Med Mol Imaging. 2006;33 Suppl 1:16-21.
-
(2006)
Eur J Nucl Med Mol Imaging
, vol.33
, Issue.1 SUPPL.
, pp. 16-21
-
-
Lammertsma, A.A.1
Hoekstra, C.J.2
Giaccone, G.3
Hoekstra, O.S.4
|